title: Ten-year survivors with multiple myeloma.
abstract: Of 130 Japanese patients with symptomatic multiple myeloma who were treated between 1970 and 1989, nine (6.9%) patients survived for more than 10 years. Younger age, low and intermediate tumour mass, chemotherapy with cyclophosphamide, the disappearance of myeloma protein, and a positive response to retreatment were correlated with long-term survival.
authors.affiliation: Third Department of Internal Medicine, Gunma University School of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Murakami
authors.forename: K
authors.initials: K
authors.lastname: Nemoto
authors.forename: S
authors.initials: S
authors.lastname: Miyawaki
authors.forename: S
authors.initials: S
authors.lastname: Shinonome
authors.forename: E
authors.initials: E
authors.lastname: Nogiwa
authors.forename: S
authors.initials: S
authors.lastname: Shimano
authors.forename: S
authors.initials: S
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Omine
authors.forename: T
authors.initials: T
authors.lastname: Naruse
authors.forename: J
authors.initials: J
authors.lastname: Tsuchiya
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000401:mortality*; D011379:Prognosis; D015996:Survival Rate